GoldenGolden
Advanced Search
Eli Lilly and Company

Eli Lilly and Company

Eli Lilly and Company is an american global pharmaceutical company founded in 1876 by Eli Lilly.

Lilly was founded in 1876 by Colonel Eli Lilly. His ambition was creating quality medicines that met real needs, during a time of deceptive medicine being sold by con men.

Disease Areas

Eli lilly and Co. mainly focus on several types of diseases for their medicines.

COVID-19 Response

On February 3rd, 2020, the company began to involves themselves in the pandemic by donating funds to the Red Cross and Direct Relief. On March 12th, it was announced that they would partner with AbCellera to develop antibody products in hopes to treat and prevent Covid-19.

A drive thru testing site was designated by the company, solely for health care workers, public safety, fire, ambulance, and public servants.

Timeline

June 24, 2021
Eli Lilly and Company launches the Leonard Award to recognize diverse champions dedicated to advancing diabetes management through innovative thinking and novel approaches.
April 13, 2021
Eli Lilly and Company announces that Diogo Rau will join the company as senior vice-president and chief information and digital officer.
February 1, 2021
Eli Lilly and Company partners with Area Health Systems to help enable access to important antibody infusion therapies for COVID-19 Patients.
November 19, 2020
Eli Lilly and Company and Ypsomed announces a non-exclusive, global agreement to advance an automated insulin delivery system as part of Lilly's connected diabetes solutions.
November 5, 2020
Eli Lilly and Company announces that Aarti Shah, Ph.D., senior vice president and chief information and digital officer, will retire in the first half of 2021.
June 8, 2020
Eli Lilly and Company announces its partner Junshi Biosciences (HKEX: 1877) has dosed the first healthy volunteer in a study of a potential neutralizing antibody treatment designed to fight COVID-19.

Acquisitions

Invested in

Patents

Products

People

Name
Role
LinkedIn

Abhinay Joshi

Employee

Abhisek Mazumdar

Employee

Abhishek Tiwari

Employee

Ahsas Ranjan

Employee

AJ Vandermeyden

Employee

...

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
MiNA Therapeutics Receives $15M Equity Investment from Eli Lilly and Company
FinSMEs
July 12, 2021
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Boehringer, Lilly: Jardiance Significantly Reduced CV Death and HF-Related Hospitalization in HFpEF
Brandon May
July 6, 2021
BioSpace
Jardiance most recently received approval by the European Commission for the treatment of adult patients with HF with ejection fraction, based on findings from the EMPEROR-Reduced trial.
Eli Lilly's Antibody Therapy for COVID-19 Paused in US and More COVID-19 News
Mark Terry
June 29, 2021
BioSpace
Here's a look at some of the top COVID-19-related stories for today.
PharmStarTM Reveals Leading Pharma Companies as Founding Members
PharmStars
June 29, 2021
www.prnewswire.com:443
/PRNewswire/ -- PharmStars, a digital-health accelerator that launched earlier this month, announces its founding pharma members: Boehringer Ingelheim, Eli...
Bajaj Healthcare seeks compulsory licence for Covid-19 drug Baricitinib
Sohini Das
June 28, 2021
@bsindia
Eli Lilly has granted voluntary license to 6 Indian drugmakers for Baricitinib
SHOW MORE

References

lilly.com
Is a
Investor
Company

Company attributes

Industry
Pharmaceutical industry
Biotechnology
Drug discovery
Biomedical engineering
Healthcare
Fermentation
Therapeutics
...
Location
Clinton, Indiana
Indianapolis
Anaheim, California
San Diego
Cambridge, Massachusetts
United States
CEO
David Ricks
Founder
Eli Lilly
Parent organization
Eli Lilly and Company
Subsidiary
ImClone Systems
Lilly Ventures
Eli Lilly and Company
‌
Lilly & Company
ARMO BioSciences
Prevail Therapeutics
Legal classification
Joint-stock company
‌
Public company
Spinout
Lilly Asia Ventures
Number of employees
38,350
Full address
893 Delaware St, Indianapolis, IN 46225 USA
CIK number
59,478
Place of incorporation
Indiana
Investors
‌
IpiNovyx Bio
DUNS Number
006421325
IRS number
350,470,950
Founded date
January 1, 1876
Competitors
Adagio Therapeutics
Stock symbol
LLY
Stock exchange
New York Stock Exchange
‌
Tokyo Stock Exchange
Former CEO
‌
Dave Ricks

Other attributes

Country
United States
Headquarters
Indianapolis
Market
Biotechnology
SIC code
2,834
Founder of
‌
Dow AgroSciences
Wikidata ID
Q632240
Owner of
Norfolk House, Basingstoke

Categories

Related Topics

Contents
Disease Areas
COVID-19 Response
Timeline
Acquisitions
Invested in
Patents
Products
People
Further reading
Documentaries, videos and podcasts
Companies
News
References
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Product
OverviewPricingEnterprise
Legal
Terms & ConditionsCommercial Terms & ConditionsPrivacy Policy
Help
Help centerAPI DocumentationContact Us
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.